WuXi AppTec, CNE100003F19

WuXi AppTec wins tenth award. WuXi AppTec stock costs EUR 22.23 at EUR 12.3 billion value

Published on 10/20/2026 at 10:49 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
WuXi AppTec won Frost & Sullivan's 2026 CRDMO award. WuXi AppTec stock costs EUR 22.23 on October 20, 2026 at a EUR 12.3 billion market value.

Recognition and operating scale

  • WuXi AppTec won a Frost & Sullivan CRDMO award for the tenth consecutive year on October 19, 2026.
  • First-half 2026 revenue reached RMB 28.90 billion and rose 38.93 percent year over year.
  • WuXi AppTec stock trades at EUR 22.23 at 10:40 a.m. CEST at Lang & Schwarz on October 20, 2026.
WuXi AppTec, CNE100003F19, Illustration mit AI erstellt.

WuXi AppTec won Frost & Sullivan's Global Company of the Year recognition for the tenth consecutive year, according to Yahoo Finance on October 19, 2026. The recognition gives the pharmaceutical services provider a current corporate milestone while its next quarterly report approaches.

Recognition adds commercial context

WuXi AppTec reported total revenue of RMB 28.90 billion for the first half ended June 30, 2026, an increase of 38.93 percent from the prior-year period. The company also raised its full-year 2026 revenue guidance to RMB 58.5 billion to RMB 60.5 billion, compared with RMB 51.3 billion to RMB 53.0 billion previously.

The award therefore arrives against a growth profile that is already visible in reported figures. Chozan listed continuing-operations backlog at RMB 66.43 billion as of June 30, 2026, which represents work awaiting execution rather than guaranteed annual sales.

What does the award mean for demand?

The commercial question is whether recognition can reinforce customer confidence in the integrated contract research, development, and manufacturing organization platform. WuXi AppTec operates across Asia, Europe, and North America and supports pharmaceutical customers through research, development, testing, and manufacturing services.

Three dated milestones

On August 3, 2026, MarketScreener reported first-half results with attributable profit up 34 percent and revenue growth. On October 7, 2026, the company received EcoVadis Gold recognition for the third consecutive year, placing it among the global top 5 percent, according to the company release carried by MarketScreener. On October 19, 2026, Frost & Sullivan named WuXi AppTec its CRDMO company of the year for the tenth consecutive year, as Yahoo Finance reported.

Next reporting date

The next scheduled company event is the third-quarter 2026 earnings release on October 26, 2026, listed in the company calendar carried by MarketScreener.

Stock quote and investor view

WuXi AppTec stock was trading at EUR 22.23 at Lang & Schwarz on October 20, 2026 at 10:40 a.m. CEST. The market capitalization stood at EUR 12.3 billion as of October 19, 2026, while the reported backlog and raised revenue guidance provide the main operating benchmarks ahead of the results.

The further course of trading is shown by the continuously updated real-time quote of WuXi AppTec stock.

WuXi AppTec key data

  • Company: WuXi AppTec Co., Ltd.
  • ISIN: CNE100003F19
  • Ticker: 603259.SH
  • Primary exchange: Shanghai Stock Exchange
  • Price Lang & Schwarz (as of October 20, 2026, 10:40 a.m. CEST): EUR 22.23
  • Market capitalization: EUR 12.3 billion (as of October 19, 2026)
  • Sector / Industry: Pharmaceuticals and biotechnology

Market context: Market report Shanghai Composite.

More news and analyses on WuXi AppTec stock

Disclaimer...
en | CNE100003F19 | WUXI APPTEC | boerse | 70371063 | bgmi